Skip to content

    BASF India

    BASFGood
    Chemicals·17 Nov 2023
    Management Summary

    BASF India delivered a resilient performance in Q2 FY24, navigating a challenging global environment characterized by soft demand and pricing pressure from China. While the top line saw a slight contraction on a half-year basis due to commodity price deflation, the Agricultural Solutions segment provided a significant profitability cushion. Management remains focused on maintaining high asset utilization (80-85%) and gradually increasing the share of own-manufactured products versus traded merchandise.

    Highlights

    7

    • H1 FY24 Revenue stood at ₹7,082 crores, a 5% decline compared to ₹7,470 crores in H1 FY23.

    • Agricultural Solutions segment profit surged to ₹300+ crores in H1, up ₹151 crores from the previous year.

    • Materials segment remains the largest contributor at 28% of total revenue, followed by Nutrition and Care.

    • Chemicals segment witnessed a significant 32% drop in top-line revenue due to crashing global prices, despite stable volumes.

    • Return on Capital Employed (ROCE) remained healthy at 12.9%, slightly lower than the previous year's 13%.

    • H1 FY24 EPS (before exceptional items) reported at ₹60 per share.

    • Inventory management improved with levels at 77 days, while receivables were maintained at 60 days.

    Concerns

    1

    • Chinese overcapacity and dumping

    Key financials

    Metrics

    6

    Periods

    2

    Headline

    3
    • ROCE
      12.9%
    • Inventory Days
      77 days
    • Receivable Days
      60 days

    H1

    3
    • Revenue
      ₹7,082 Cr
      YoY-5.2%QoQ+3%
    • PBT before Exceptional Items
      —
      YoY-15%
    • EPS
      ₹60

    Segment breakdown

    Agricultural Solutions
    ₹1,200 Cr Revenue (H1)₹300 Cr Profit (H1)17% Revenue Share
    Materials
    28% Revenue Share— Volume Trend
    Chemicals
    -32% Top-line Growth— Volume Trend
    Industrial Solutions
    -1.8% Segment Result Growth
    List

    Guidance & targets

    3
    CategoryTargetPriority
    Capacity
    Capacity Utilization
    80-85%
    		High
    Other
    Own Manufacturing Share
    >50%
    		Medium
    Capex
    H1 Capex Spend
    ₹45-50 crores
    		High

    Risks & concerns

    6
    RiskSeverity

    Chinese overcapacity and dumping

    Excess capacity in China is leading to low-priced exports into India, putting severe pressure on margins in the Chemicals and Materials segments. — Both acknowledged

    high

    Global demand softness

    Demand remains soft in major markets like Asia, Europe, and North America, impacting the global chemical industry context. — Management

    medium

    Energy price volatility

    Higher energy prices continue to put pressure on margins from the cost side. — Management

    medium

    Areas of Evasion(3)

    • Specific future capex numbers
    • 3-5 year business roadmap/guidance
    • Specific revenue share of top 3 Agri products

    Q&A highlights

    3

    “Fortunately we don't have you know significant Channel inventory because we do not aggressively push into the channel since we place our products also to application timeline.”

    Confirms that the strong Agri performance is driven by actual demand and digital tracking (ACT shop) rather than channel stuffing.

    asked by Varun Bang, Bryanstone Investments

    2 min read5 chapters

    Detailed Narrative

    01

    Agricultural Solutions Anchors Profitability

    The Agricultural Solutions segment was the standout performer, with H1 profits reaching ₹300+ crores, a significant jump from ₹160 crores in the previous year. This was achieved despite a delayed and dry monsoon, which management mitigated by proactively adjusting the product mix toward insecticides and herbicides. The successful launch of 'Exponus', a blockbuster insecticide, has helped the company capture market share in the large Indian insecticide market where it was previously weak.

    02

    Working Capital and Inventory Discipline

    BASF India maintained a tight grip on its balance sheet, reporting net working capital of approximately ₹1,200 crores. Inventory levels were managed down to 77 days, which management considers an achievement given that 80% of materials are imported and require 2-3 months of lead time. Receivables were also well-controlled at 60 days, with overdues kept below 10%, reflecting a disciplined 'cash-before-sales' approach in challenging market conditions.

    03

    Navigating the 'China Factor' and Pricing Pressure

    The Chemicals segment saw a 32% drop in top-line revenue, purely driven by price deflation as volumes remained stable. Management attributed this to global overcapacity and 'dumping' from China due to soft domestic demand there. While they see 'early signs' of demand picking up in China, they remain cautious, noting that the competitive intensity remains high across all segments except Agriculture.

    04

    Strategic Shift Toward Own Manufacturing

    The company currently maintains a 50:50 ratio between own-manufactured products and traded merchandise. Management expressed a clear ambition to increase the share of own manufacturing over time to capture better margins, which are typically double-digit compared to single-digit margins in trading. Current capacity utilization is at an 'optimum' level of 80-85%, and incremental investments are being directed toward debottlenecking and expanding lines in Panoli and Mangalore.

    05

    Digitalization via 'ACT Shop'

    A key highlight of the call was the success of the 'ACT shop' digital platform for the Agricultural Solutions business. Currently, 99% of all B2C orders are placed through this platform, allowing for real-time data tracking and inventory visibility across the country. This digital edge enables the company to move inventory efficiently to regions with high demand during erratic monsoon seasons, avoiding the 'gut-feeling' based distribution common in the industry.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.